While the condition is treatable, the seriousness of the diagnosis and the intensity of the treatment can be so traumatic that some AML patients have compared it to being abducted.
Mass General Cancer Center investigators found that nine percent of esophageal adenocarcinoma patients harbor mutations in cancer-predisposing genes, shedding light on the causes of progression to the disease and new possibilities for screening and treatment.
Among both men and women, non-smokers and smokers, lung cancer remains the leading cause of cancer-related death. n recognition of Lung Cancer Awareness Month, Massachusetts General Hospital physicians answer common questions related to lung cancer.
Read about what the new FDA approval of an over-the-counter birth control pill means for you, with insights from physicians in the Department of Obstetrics and Gynecology at Massachusetts General Hospital.
Targeted therapies induced tumor expression of the APOBEC3A protein, which was shown to directly cause new mutations and accelerate the development of drug resistance.
Mass General Cancer Center’s precision medicine approach resulted in 91 percent reduction in tumor size, with all 15 patients who received one or more cycles of therapy responding to treatment.
Read this question-and-answer article featuring Allison Gockley, MD, a gynecologic oncologist in the Department of Obstetrics and Gynecology and Mass General Cancer Center.
Faced with a breast cancer diagnosis, Katie Britton turned to resources at the Mass General Cancer Center to help keep her mind and body well during treatment. Read her patient story.
In multi-year study, Mass General Cancer Center researchers found increase in rates for liver cancer deaths among Hispanic men and rates for liver, pancreatic, and uterine cancer deaths among Hispanic women.
Given the economic impact of cancer care and periodontitis (gum disease) on the increasingly aging population, researchers explore the potential interplay of the oral microbiome and cancer immunotherapy.
An integral part of one of the world’s most distinguished academic medical centers, Mass General Cancer Center is among the leading cancer care providers in the United States.
